Skip to content
Psilocybin Research

Work with us

Licensed data, commissioned analysis, and collaboration — for teams that have to cite a source and need it to still be right in six months.

PartnershipsReviewed

The short answer

We license our datasets, write commissioned briefings, and collaborate with research institutions. Every figure traces to a primary source: 15 training programs from the state regulator’s approved list, 133 recruiting trials from ClinicalTrials.gov, 2 of 51 jurisdictions checked against the statute. That sourcing is what a licensee is buying.

What we do

Ways to work together

Every client here needs the research to survive scrutiny. So does every reader.

Data licensing

The legal dataset and the trials registry as structured data, on a set refresh cadence, with a citable review date.

Typically: Insurers, health systems, state agencies, law firms, investors

Commissioned briefings

Written analysis on one question. What a state's program permits, how a trial's endpoints compare with its coverage, what an FDA action changes. Delivered to you rather than published.

Typically: Policy teams, benefits designers, journalists on longer projects

Academic collaboration

Co-maintaining a dataset, contributing to a review, or opening the registry to a research group. Free where the output is public.

Typically: Universities, research centers, non-profits

Sponsorship

Support from an organization with nothing to sell our readers. Disclosed on the page, editorially separate, and ours to end.

Typically: Foundations, grant-making bodies, professional associations

Getting in touch

Tell us what you need and roughly when. This reaches a person, not a queue, and you will get a real answer — including a no, with the reason, if that is the answer.

Three things worth saying up front, because they save everyone time. We will not sign anything that gives a funder approval over what we publish. We will always disclose a commercial relationship on the pages it could touch. And if we think the work would compromise the site, we will say so and tell you why rather than quoting a price we hope you decline.

What’s this about?

The legal dataset, the trials registry, or both.

We use your address to reply, and nothing else. Please don’t send medical records.

Or write directly to [email protected].

Common questions

Questions about working with us

Does Psilocybin Research accept advertising?
Not from psilocybin sellers, service providers, retreats, clinics, coaching programs or supplement companies — which is most of the advertising available in this category. We license our datasets, write commissioned briefings, and will take sponsorship from organizations with nothing to sell our readers, disclosed on the page and with no editorial input.
Do you take affiliate commission?
There are no affiliate links anywhere on this site today, including on the pages where they would be easiest to place — facilitator training, events and cost all link out, and none of those links earns us anything. Outbound links carry nofollow. Commission on books and other non-consumable products is a planned stream, itemized in the advertising disclosure; commission on psilocybin, spores, grow kits or any consumable is a permanent refusal.
Can we sponsor a page or be listed in the training or events directories?
Listings cannot be bought. Presence on the approved-training page is decided by a state regulator, presence on the events page is decided by whether the event exists and what kind it is, and presence in the trials registry is decided by ClinicalTrials.gov. Sponsorship, where we accept it, funds the publication as a whole and is disclosed — it never attaches to a page or a listing.
What data can we license?
The 51-jurisdiction legal status dataset, reviewed by hand and last updated August 30, 2026, and the psilocybin trials registry, currently 133 recruiting studies pulled from ClinicalTrials.gov with washout requirements flagged. Both come with a review date, a documented methodology and a named person to ask.
Will you write about our company?
Possibly — on the same terms as everyone else. We cover the development pipeline, state programs and the training market as reported facts, so a company appears here when the facts warrant it. Coverage is earned rather than arranged, and it is a record rather than an endorsement.